Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ATP SYNTHESIS | 170 | |||||||
| ATP HYDROLYSIS | 170 | |||||||
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| F1 subunits | 170 | |||||||
| F1 subunits | 170 | |||||||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
![]() ![]() |
Danger |
Aggregated GHS information provided by 163 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H301 (23.31%): Toxic if swallowed [Danger Acute toxicity, oral] H302 (71.17%): Harmful if swallowed [Warning Acute toxicity, oral] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P264, P270, P301+P310, P301+P312, P321, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 1-Chloro-4-nitrobenzoxadiazole | 10199-89-0 | 199C890 |
| 2,1,3-Benzoxadiazole, 4-chloro-7-nitro- | 4-CHLORO-7-NITRO-BENZO[1,2,5]OXADIAZOLE | 4-CHLORO-7-NITROBENZ-2-OXA-1,3-DIAZOLE |
| 4-Chloro-7-nitro-2,1,3-benzoxadiazole | 4-Chloro-7-nitro-2,1,3-benzoxadiazole # | 4-Chloro-7-nitro-benzo[c][1,2,5]oxadiazole |
| 4-Chloro-7-nitro-benzoxa[1,3]diazole | 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole | 4-Chloro-7-nitrobenzo[c][1,2,5]oxadiazole |
| 4-Chloro-7-nitrobenzofurazan | 4-Chloro-7-nitrobenzofurazan, 98% | 4-Chloro-7-nitrobenzofurazan, BioReagent, suitable for fluorescence, >=97.0% (HPLC) |
| 4-Chloro-7-nitrobenzofurazane | 4-Nitro-7-chlorobenzofurazan | 4-chloro-7-nitro 2,1,3-benzoxadiazole |
| 4-chloro-7-nitro-benzofurazan | 4-chloro-7-nitrobenzo-2,1,3-oxadiazole | 4-chloro-7-nitrobenzo[c]1,2,5-oxadiazole |
| 7-CHLORO-4-NITROBENZ-2-OXA-1,3-DIAZOLE | 7-Chloro-4-nitrobenzo-2-oxa-1,3-diazole | 7-Chloro-4-nitrobenzofurazan |
| 7-Nitro-4-chlorobenzofurazan | 7-chloro-4-nitro-benzofurazan | AC-24649 |
| ACN-048974 | AKOS000121286 | ALBB-020690 |
| AM85450 | AMBZ0375 | AS-64042 |
| BBL011971 | BENZOFURAZAN, 4-CHLORO-7-NITRO- | BRN 0614212 |
| C6H2ClN3O3 | CHEBI:78878 | CHEMBL1743207 |
| CS-7530 | CTK8E4966 | Chloronitrobenzoxadiazole |
| DTXSID2064995 | EINECS 233-496-4 | EQF2794IRE |
| EU-0033246 | FT-0618144 | HY-D0042 |
| J-100055 | J-610037 | LS-35358 |
| MCULE-4610896893 | MFCD00005808 | NBD chloride, 98% |
| NBD-C 1 | NBD-Cl | NBD-chloride |
| NBF-Cl | NS00023098 | NSC 228140 |
| NSC-228140 | NSC228140 | Nbd chloride |
| Nitrobenzoxadiazole Chloride | Q229939 | QC-1844 |
| SBB005345 | SCHEMBL16305393 | SCHEMBL41754 |
| SR-01000596972 | SR-01000596972-1 | ST033521 |
| STK728793 | Shokat-update-comp17 | UNII-EQF2794IRE |
| UPCMLD0ENAT5654999:001 | ZINC1311094 | nchembio866-comp17 |
| CAS Number | 10199-89-0 |
| PubChem Compound | 25043 |